UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

British journal of dermatology (1951), 2020-08, Vol.183 (2), p.242-255

2020

Volltextzugriff (PDF)

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, 2022-09, Vol.36 (9), p.1486-1496

2022

Volltextzugriff (PDF)

THU0166 Safety Profile of Baricitinib in Patients with Active RA: An Integrated Analysis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.243

2016

Volltextzugriff (PDF)

Biomarkers of inflammation and endothelial function: The holy grail of experimental and clinical medicine?

Vascular pharmacology, 2012-01, Vol.56 (1), p.26-28

2012

Volltextzugriff (PDF)

OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.75-76

2015

Volltextzugriff (PDF)

Nat3p and Mdm20p Are Required for Function of Yeast NatB Nα-terminal Acetyltransferase and of Actin and Tropomyosin

The Journal of biological chemistry, 2003-08, Vol.278 (33), p.30686-30697

2003

Volltextzugriff (PDF)

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

European journal of cancer (1990), 2003-02, Vol.39 (3), p.397-404

2003

Volltextzugriff (PDF)

192 Assessing treatment effect of baricitinib in atopic dermatitis using digital endpoints derived from actigraphy data: nocturnal scratch and sleep disturbance

Journal of investigative dermatology, 2023-11, Vol.143 (11), p.S364

2023

Volltextzugriff (PDF)

084 Herpes virus infections amongst moderate to severe atopic dermatitis patients treated with baricitinib: an integrated analysis of phase 3 trials

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S162-S162

2021

Volltextzugriff (PDF)

041 Efficacy with continuous dosing, down-titration, or treatment withdrawal after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S155-S155

2021

Volltextzugriff (PDF)

Role of cytochrome c heme lyase in mitochondrial import and accumulation of cytochrome c in Saccharomyces cerevisiae

Molecular and Cellular Biology, 1991-11, Vol.11 (11), p.5487-5496

1991

Volltextzugriff (PDF)

Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer

Clinical cancer research, 2001-10, Vol.7 (10), p.3186-3192

2001

Volltextzugriff (PDF)

Epithelial Mucin-1 (MUC1) Expression and MA5 Anti-MUC1 Monoclonal Antibody Targeting in Multiple Myeloma

Clinical cancer research, 1999-10, Vol.5 (10), p.3065s-3072s

1999

Volltextzugriff (PDF)

Specialists leave fewer descendants within a region than generalists

Global ecology and biogeography, 2013-02, Vol.22 (2), p.213-222

2013

Volltextzugriff (PDF)

Analysis of mutationally altered forms of the Cct6 subunit of the Chaperonin from Saccharomyces cerevisiae

Genetics (Austin), 1997-12, Vol.147 (4), p.1609-1633

1997

Volltextzugriff (PDF)

THU0166 Safety Profile of Baricitinib in Patients with Active RA: An Integrated Analysis: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.243-244

2016

Volltextzugriff (PDF)

HIGH SENSITIVITY TROPONIN ASSAY FOR EARLY DIAGNOSIS OF ACUTE CORONARY SYNDROME IN A REAL-WORLD SITUATION: COMPARISON BETWEEN HS-TNT, LOCI HS-TNI, HS-TNI ROCHE AND CONVENTIONAL TNT

Journal of the American College of Cardiology, 2010-03, Vol.55 (10), p.A118.E1106-A118.E1106

2010

Volltextzugriff (PDF)

Requirements of Cyc2p and the Porin, Por1p, for Ionic Stability and Mitochondrial Integrity in Saccharomyces cerevisiae

Archives of biochemistry and biophysics, 2001-08, Vol.392 (2), p.326-332

2001

Volltextzugriff (PDF)

CYC2 encodes a factor involved in mitochondrial import of yeast cytochrome c

Molecular and Cellular Biology, 1993-10, Vol.13 (10), p.6442-6451

1993

Volltextzugriff (PDF)

Enhanced thermodynamic stabilities of yeast iso-1-cytochromes c with amino acid replacements at positions 52 and 102

The Journal of biological chemistry, 1991-06, Vol.266 (18), p.11686-11694

1991

Volltextzugriff (PDF)

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial

Thrombosis and haemostasis, 2014-08, Vol.112 (2), p.311-322

2014

Volltextzugriff (PDF)

Tcp20, a subunit of the eukaryotic TRiC chaperonin from humans and yeast

The Journal of biological chemistry, 1994-07, Vol.269 (28), p.18616-18622

1994

Volltextzugriff (PDF)

Ranolazine in the treatment of chronic stable angina

Clinica terapeutica, 2012, Vol.163 (3), p.231

2012

Volltextzugriff (PDF)

Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor

Cancer research (Chicago, Ill.), 1995-09, Vol.55 (17), p.3817-3824

1995

Volltextzugriff (PDF)

Efficacité et tolérance du baricitinib dans la dermatite atopique modérée à sévère: résultats de deux études de phase 3 en monothérapie sur 16 semaines, randomisées, en double-aveugle, contrôlées versus placebo (BREEZE-AD1 et BREEZE AD-2)

Annales de dermatologie et de vénéréologie, 2019-12, Vol.146 (12), p.A109-A111

2019

Volltextzugriff (PDF)

1 – 25 von 3.678

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.750)
Mit Volltextzugriff
(2.994)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

THU0166 Safety Profile of Baricitinib in Patients with Active RA: An Integrated Analysis

Biomarkers of inflammation and endothelial function: The holy grail of experimental and clinical medicine?

OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study

Nat3p and Mdm20p Are Required for Function of Yeast NatB Nα-terminal Acetyltransferase and of Actin and Tropomyosin

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

192 Assessing treatment effect of baricitinib in atopic dermatitis using digital endpoints derived from actigraphy data: nocturnal scratch and sleep disturbance

084 Herpes virus infections amongst moderate to severe atopic dermatitis patients treated with baricitinib: an integrated analysis of phase 3 trials

041 Efficacy with continuous dosing, down-titration, or treatment withdrawal after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis

Role of cytochrome c heme lyase in mitochondrial import and accumulation of cytochrome c in Saccharomyces cerevisiae

Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer

Epithelial Mucin-1 (MUC1) Expression and MA5 Anti-MUC1 Monoclonal Antibody Targeting in Multiple Myeloma

Specialists leave fewer descendants within a region than generalists

Analysis of mutationally altered forms of the Cct6 subunit of the Chaperonin from Saccharomyces cerevisiae

THU0166 Safety Profile of Baricitinib in Patients with Active RA: An Integrated Analysis: Table 1

HIGH SENSITIVITY TROPONIN ASSAY FOR EARLY DIAGNOSIS OF ACUTE CORONARY SYNDROME IN A REAL-WORLD SITUATION: COMPARISON BETWEEN HS-TNT, LOCI HS-TNI, HS-TNI ROCHE AND CONVENTIONAL TNT

Requirements of Cyc2p and the Porin, Por1p, for Ionic Stability and Mitochondrial Integrity in Saccharomyces cerevisiae

CYC2 encodes a factor involved in mitochondrial import of yeast cytochrome c

Enhanced thermodynamic stabilities of yeast iso-1-cytochromes c with amino acid replacements at positions 52 and 102

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial

Tcp20, a subunit of the eukaryotic TRiC chaperonin from humans and yeast

Ranolazine in the treatment of chronic stable angina

Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor

Efficacité et tolérance du baricitinib dans la dermatite atopique modérée à sévère: résultats de deux études de phase 3 en monothérapie sur 16 semaines, randomisées, en double-aveugle, contrôlées versus placebo (BREEZE-AD1 et BREEZE AD-2)

Suchergebnisse filtern